Catalyst Wire Dossier Catalyst Wire Dossier

GB18 Injection

GB18 · Kexing Biopharm Co., Ltd.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for GB18 Injection, covering 2025-11-19 to 2026-04-09. Get the full timeline:

Most recent: Clinical Trial Update: A Phase I Clinical Study to Evaluate the PK, PD, Efficacy, and Safety of GB18 Injection in Patients With Tumor Cachexia [Phase 1]

See pricing